Investment analysts at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research note issued on Thursday. The brokerage set a “sell” rating on the medical technology company’s stock. A number of other equities research analysts have also recently weighed in on the company. Benchmark restated a “speculative buy” rating and […]
StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a report issued on Wednesday morning. The brokerage issued a sell rating on the medical technology company’s stock. Separately, Benchmark reaffirmed a speculative buy rating and set a $2.00 price objective on shares of BIOLASE in a research report on Wednesday, March 29th. […]
/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously.
StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a report released on Tuesday morning. The firm issued a sell rating on the medical technology company’s stock. Other research analysts also recently issued reports about the company. Benchmark reissued a speculative buy rating and issued a $2.00 price objective on shares of […]
StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a report published on Tuesday. The firm issued a sell rating on the medical technology company’s stock. Other equities research analysts also recently issued research reports about the company. Benchmark restated a speculative buy rating and issued a $2.00 target price on shares […]